Future of healthcare discussions held at Health Horizons in Cambridge

Lindsey Brown Written by Lindsey Brown
Published on 01 July 2019
4 min. read

The city of Cambridge, a global hub for research and healthcare innovation, played host to more than 150 speakers in the field of healthcare and biotechnology last week, and shone a spotlight on the future of healthcare and innovation as part of Health Horizons Future Healthcare Forum on 26 and 27 June 2019. Sponsored by the Headline Partner, Pfizer, Gold Sponsors AstraZeneca and Barclays Eagle Labs as well as other leading industry players, the 2-day conference was a huge success and received positive praise and feedback from attendees hailing from as far as Hong Kong and Australia.

The event, which was part of the Cambridge BioTech Week, aims to analyse the gaps, challenges and unmet needs of the current global healthcare ecosystem. Speakers and delegates discussed key topics such as novel therapeutic approaches, digital health, longevity, CNS and nano-technology, all with the aim of defining goals for the biopharma and healthcare industry, connecting investment capital with biotech start-ups and identifying strategies, policy and technological solutions that will improve healthcare in the future.

Speakers included Pfizer’s Chief Medical Officer, Dr Rory O’Connor talking about controlled vs. uncontrolled clinical trials, AstraZeneca’s Senior Vice President of Clinical Pharmacology & Safety Sciences, Dr Stefan Platz, highlighting the power of precision medicine, and Director of Barclays UK Ventures, Ana Perales discussing key learnings from the financial industry on clinical data security and quality with AstraZeneca’s Chief Medical Officer, Ann Taylor

As part of the managing cancer session, Jane Grogan, discussed why Genentech is betting big on neoantigen-targeted therapies with Roche’s Anna Williamson in an exclusive fireside chat. 

The event also held the finals of the Innovation Forum’s global accelerator
IMAGINE IF! Sponsored by Johnson & Johnson Innovation, the Finals were judged by seasoned investors and pharma experts including Chair, Ann Connolly, Johnson & Johnson Innovation, Nicolas Ibery, Health and Life Sciences, Edward Rayner, Arix Bioscience and Stephen Chan, Co-High Venture Capital Fund (China).  London-based startup Jelly Drops, received the winning prize of $10,000 of funding and 6 months lab space for their innovative solution for hydration issues in those living with dementia in the form of a hydrating treat.

A key highlight of the second day was the panel discussion on evolving landscapes of healthcare innovation investment chaired by Dr Sonia Benhamida (DNB Bank), which featured, among others, Makoto Ohori, Astellas Pharma Inc, Pavithra Sundaresen, Johnson & Johnson Innovation and Ed Rayner from Arix Bioscience.  

Health Horizons together with partners Cambridge Innovation Capital also facilitated connections between startups and investors by arranging ‘pitch in a punt’ sessions along the River Cam where successful applicants had the opportunity to pitch their product or idea to leading investors.

Dr Marek Tyl, CEO of the Innovation Forum, which organises the Health Horizons – Future Healthcare Forum, says:

“We are very pleased with the outcome of the conference. The Health Horizons Future Healthcare Forum is a thought leadership meeting gathering top brains in the healthcare industry and working with our speakers and partners we will continue shaping the agenda for a healthier future.”

Although Health Horizons may be over for this year, the discussions will continue to flow, and conclusions made will influence healthcare in a positive, inspiring way for the future. Watch this space for news about future editions of the Health Horizons Forum.

For more information, visit the Health Horizons website at: www.horizons.health

Share content

Leave a Reply

In order to comment you need to be part of Inno-Forum. If you’re already a member Log in or Register

We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.